The 2,3,4,5,6-pentaphenyl-1,2-azaborinin-1-yl (PPAB) potassium complex 1 undergoes facile salt metathesis with 9,10-dibromo-9,10-dihydroboraanthracene (DBA), 5-bromodibenzo[,]borole (DBB), 1-chlorotetraphenylborole (TPB) and dibromo(phenyl)borane (BBrPh) to yield the corresponding -borylated azaborinines -DBA-PPAB (2, which hydrolyses and dimerises to the oxo-bridged ,'-O(DBA)-(PPAB), 3), ,'-DBA-(PPAB) (4), -DBB-PPAB (5), -PPB-PPAB (7) and -BBrPh-PPBA (9). Stepwise reduction of 4 yields the corresponding stable radical anion 4˙- and dianion 42-. One-electron reduction of 5 with KC yields the purple radical anion 5˙-, which forms a highly insoluble coordination polymer. 5˙- undergoes very slow radical intramolecular -C-H activation at the C4-phenyl substituent of the PPAB moiety, yielding a BN-analogue of the 5,5'-spiro-bi[dibenzoborole] anion, [6]K. Compound 7 cannot be isolated and undergoes spontaneous and diastereoselective 2,5--addition of the -C-H bond of the PPAB C4-phenyl substituent to yield a novel BNB-analogue of the triply fused dihydrocyclopenta[]phenanthrene cation, compound 8. Finally the one-electron reduction of 9 results in the -C-H activation of the PPAB C4-phenyl substituent at an -generated dicoordinate boryl anion (10), resulting in the formation of a BNB-analogue of 9-fluorene, the borate 11-. DFT calculations provide a rationale for the diverse C-H activations observed in these reactions.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d3dt03826bDOI Listing

Publication Analysis

Top Keywords

c4-phenyl substituent
12
reduction yields
8
radical anion
8
one-electron reduction
8
-c-h activation
8
ppab c4-phenyl
8
synthesis reduction
4
reduction c-h
4
c-h activation
4
activation chemistry
4

Similar Publications

The 2,3,4,5,6-pentaphenyl-1,2-azaborinin-1-yl (PPAB) potassium complex 1 undergoes facile salt metathesis with 9,10-dibromo-9,10-dihydroboraanthracene (DBA), 5-bromodibenzo[,]borole (DBB), 1-chlorotetraphenylborole (TPB) and dibromo(phenyl)borane (BBrPh) to yield the corresponding -borylated azaborinines -DBA-PPAB (2, which hydrolyses and dimerises to the oxo-bridged ,'-O(DBA)-(PPAB), 3), ,'-DBA-(PPAB) (4), -DBB-PPAB (5), -PPB-PPAB (7) and -BBrPh-PPBA (9). Stepwise reduction of 4 yields the corresponding stable radical anion 4˙- and dianion 42-. One-electron reduction of 5 with KC yields the purple radical anion 5˙-, which forms a highly insoluble coordination polymer.

View Article and Find Full Text PDF

Investigation of selective retinoic acid receptor alpha antagonist ER-50891 and related analogs for male contraception.

Arch Pharm (Weinheim)

July 2023

Department of Medicinal Chemistry, Institute for Therapeutics Discovery and Development, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.

Retinoic acid receptor alpha (RARα) antagonist ER-50891 and 15 analogs were prepared and tested in vitro for potency and selectivity at RARα, RARβ, and RARγ using transactivation assays. Minor modifications to the parent molecule such as the introduction of a C4 tolyl group in place of the C4 phenyl group on the quinoline moiety slightly increased the RARα selectivity but larger substituents significantly decreased the potency. Replacement of the pyrrole moiety of ER-50891 with triazole, amides, or a double bond produced inactive compounds.

View Article and Find Full Text PDF

Modified norcyanines enable ratiometric pH imaging beyond 1000 nm.

Biosens Bioelectron

December 2022

Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, United States. Electronic address:

Activatable fluorophores with emission beyond 1000 nm have the potential to enable high contrast imaging in complex in vivo settings. However, there are few scaffolds that can be applied to this challenge. Here we detail the synthesis and evaluation of benzo[c,d]indole-substituted norcyanines that enable pH responsive fluorescence imaging in the long wavelength (>1150 nm) range.

View Article and Find Full Text PDF

Inhibition of human cytochrome P450 2A6 by 7-hydroxycoumarin analogues: Analysis of the structure-activity relationship and isoform selectivity.

Eur J Pharm Sci

August 2019

The Affiliated Hospital of Southwest Medical University, Luzhou, China; The Pharmacy School of Southwest Medical University, Luzhou, China; Institute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang University, Hangzhou, China; Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, China. Electronic address:

Compared with coumarin, 7-hydroxycoumarin could serve as a better hit for developing CYP2A6 inhibitors. In this study, a series of 7-hydroxycoumarin and its structural analogues were collected to study their structure-activity relationship (SAR) and isoform selectivity for inhibiting CYP2A6. All tested coumarins except a C4 phenyl derivative (11) showed higher inhibitory activities for CYP2A6 over the other CYP isoforms, including CYP1A2, CYP2D6, CYP2E1, CYP3A4, CYP2C8, and CYP2C9.

View Article and Find Full Text PDF

AKR1C3 is a promising therapeutic target for castration-resistant prostate cancer. Herein, an evaluation of in-house library discovered substituted pyranopyrazole as a novel scaffold for AKR1C3 inhibitors. Preliminary SAR exploration identified its derivative 19d as the most promising compound with an IC of 0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!